Adverse Reactions (6.1).] Maintenance of JANUVIA During Initiation and Titration of Insulin Glargine A total of 746 patients with type 2 diabetes (mean baseline HbA1C 8.8%, disease duration 10.8 years) participated in a 30-week, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of continuing JANUVIA during the initiation and uptitration of insulin glargine
The combination of CJC 1295 and Ipamorelin creates a powerful peptide therapy that enhances growth hormone release through distinct but complementary mechanisms: CJC 1295 Mechanism : By mimicking GHRH, CJC 1295 binds to receptors in the pituitary gland, encouraging a sustained release of growth hormone
Ju, H., Zou, R., Venema, V
Single-walled carbon nanotubes (SWCNTs) behave as good free radical scavengers in the front lines of theoretical models
( Epub 2013/05/04 )